Bill > S2760

This bill, called the Reducing Hereditary Cancer Act of 2025, aims to expand Medicare coverage for individuals with a high genetic risk of developing cancer by introducing several key provisions. The legislation would allow Medicare to cover genetic testing (called germline mutation testing) for people with a personal or family history of hereditary cancer gene mutations, following guidelines from recognized oncology professional organizations. Additionally, the bill would enable Medicare to cover preventive surgeries that could reduce cancer risk for individuals with specific inherited mutations, based on evidence-based clinical practice guidelines. The bill also expands coverage for cancer screenings for high-risk individuals, allowing for more frequent screenings including mammography, breast MRI, colonoscopy, PSA testing, and other appropriate screening methods. These screenings would be available at least annually for individuals determined to have a hereditary cancer gene mutation. By addressing genetic testing, preventive surgeries, and screening frequency, the bill seeks to provide more comprehensive and proactive healthcare for people with inherited cancer risks, potentially enabling earlier detection and prevention of cancer.

Budget and Finance

https://www.congress.gov/bill/119th-congress/senate-bill/2760/all-info